Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: A case–control study

This study aimed to evaluate the long-term outcome and toxicities in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by concurrent chemoradiotherapy (CCRT) with/without adding cetuximab. | Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma A case control study

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN